These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24531312)

  • 1. Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population.
    Ni M; Zhang WZ; Qiu JR; Liu F; Li M; Zhang YJ; Liu Q; Bai J
    Sci Rep; 2014 Feb; 4():4112. PubMed ID: 24531312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis.
    Xin Y; Hao S; Lu J; Wang Q; Zhang L
    PLoS One; 2014; 9(4):e95966. PubMed ID: 24763305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSTP1, ERCC1 and ERCC2 polymorphisms, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in colorectal cancer in Chinese population.
    Li HY; Ge X; Huang GM; Li KY; Zhao JQ; Yu XM; Bi WS; Wang YL
    Asian Pac J Cancer Prev; 2012; 13(7):3465-9. PubMed ID: 22994779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERCC1 and XPD/ERCC2 polymorphisms' predictive value of oxaliplatin-based chemotherapies in advanced colorectal cancer has an ethnic discrepancy: a meta-analysis.
    Lu X; Xiao S; Jin C; van der Straaten T; Li X
    J Clin Lab Anal; 2012 Jan; 26(1):10-5. PubMed ID: 24833529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum.
    Liao WY; Ho CC; Tsai TH; Chen KY; Shih JY; Yu CJ
    Lung Cancer; 2018 Apr; 118():90-96. PubMed ID: 29572009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERCC1 and ERCC2 polymorphisms and risk of idiopathic azoospermia in a Chinese population.
    Ji G; Gu A; Xia Y; Lu C; Liang J; Wang S; Ma J; Peng Y; Wang X
    Reprod Biomed Online; 2008 Jul; 17(1):36-41. PubMed ID: 18616887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of genetic polymorphisms in ERCC1 and ERCC2/XPD with risk of chronic benzene poisoning in a Chinese occupational population.
    Xiao S; Gao L; Liu Y; Yu T; Jin C; Pan L; Zhu G; Lu X
    Mutat Res; 2013 Feb; 751(1):52-8. PubMed ID: 23147699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival.
    Salimzadeh H; Lindskog EB; Gustavsson B; Wettergren Y; Ljungman D
    BMC Cancer; 2020 May; 20(1):409. PubMed ID: 32397974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk.
    Zhou CX; Zhao JH
    Genet Mol Res; 2015 Mar; 14(1):2868-75. PubMed ID: 25867436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in ERCC1 and ERCC2/XPD genes and carcinogen DNA adducts in human lung.
    Lee MS; Liu CY; Su L; Christiani DC
    Lung Cancer; 2015 Jul; 89(1):8-12. PubMed ID: 26001533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of four ERCC1 and ERCC2 SNPs with survival of bone tumour patients.
    Hao T; Feng W; Zhang J; Sun YJ; Wang G
    Asian Pac J Cancer Prev; 2012; 13(8):3821-4. PubMed ID: 23098477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A haplotype encompassing the variant allele of DNA repair gene polymorphism ERCC2/XPD Lys751Gln but not the variant allele of Asp312Asn is associated with risk of lung cancer in a northeastern Chinese population.
    Yin J; Vogel U; Ma Y; Qi R; Sun Z; Wang H
    Cancer Genet Cytogenet; 2007 May; 175(1):47-51. PubMed ID: 17498557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HapMap-based study of a region encompassing ERCC1 and ERCC2 related to lung cancer susceptibility in a Chinese population.
    Yin J; Vogel U; Ma Y; Qi R; Wang H; Yue L; Liang D; Wang C; Li X; Song T
    Mutat Res; 2011 Aug; 713(1-2):1-7. PubMed ID: 21601580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERCC1 and ERCC2 variants predict survival in gastric cancer patients.
    Li Y; Liu Z; Liu H; Wang LE; Tan D; Ajani JA; Wei QY
    PLoS One; 2013; 8(9):e71994. PubMed ID: 24023723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
    Mo J; Luo M; Cui J; Zhou S
    Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer.
    He MG; Zheng K; Tan D; Wang ZX
    Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERCC2, ERCC1 polymorphisms and haplotypes, cooking oil fume and lung adenocarcinoma risk in Chinese non-smoking females.
    Yin Z; Su M; Li X; Li M; Ma R; He Q; Zhou B
    J Exp Clin Cancer Res; 2009 Dec; 28(1):153. PubMed ID: 20003391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy.
    Liu R; Zhao X; Liu X; Chen Z; Qiu L; Geng R; Guo W; He G; Yin J; Li J; Zhu X
    Tumour Biol; 2016 Feb; 37(2):1753-62. PubMed ID: 26314858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between the ERCC1/2 polymorphisms and the clinical outcomes of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis.
    Yang Y; Xian L
    Tumour Biol; 2014 Apr; 35(4):2905-21. PubMed ID: 24338713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population.
    Zhao R; Ying MF
    Genet Mol Res; 2016 Mar; 15(1):15017263. PubMed ID: 26985954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.